Neurogenomics Market: Size, Share, Forecasts, & Trends Analysis

 Meticulous Research® has published an extensive report titled “Neurogenomics Market—Global Opportunity Analysis & Industry Forecast to 2031.” The report indicates that the neurogenomics market is on track to reach $4.68 Billion by 2031, with an anticipated CAGR of 16.6% from 2024 to 2031.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6019

The driving forces behind the growth of the neurogenomics market include several critical factors such as decreasing sequencing costs, a surge in neurological disorder prevalence, and an increased adoption of advanced sequencing technologies for diagnostics and precision medicine. Additional contributors to market growth are growing pharmaceutical R&D investments, improvements in regulatory and reimbursement frameworks concerning gene sequencing, rising healthcare expenditure, increased funding for research, a growing necessity for early detection and preventive measures for neurological disorders, advancements in neurogenomics technologies, and government initiatives that promote sequencing in clinical and research settings.

Nevertheless, certain challenges pose risks to market expansion. These include high costs of neurogenomics products, limited opportunities to identify actionable mutations for precision medicine, and various ethical and legal issues linked to sequencing-based diagnostics.

Moreover, the rising adoption of targeted therapies, burgeoning emerging economies, and heightened awareness of neurological disorders are likely to create growth opportunities for market participants. Nonetheless, challenges such as a dynamic regulatory landscape, limited expertise and sequencing capabilities in small to medium-sized laboratories, a shortage of skilled sequencing professionals, and the significant capital investment necessary for sequencing infrastructure could impede market growth.

Key Players

The neurogenomics market remains moderately competitive, featuring a mix of both large and small regional and local players. The prominent key players in the neurogenomics market include:

  • Illumina, Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • QIAGEN N.V. (Netherlands)
  • Agilent Technologies, Inc. (U.S.)
  • Revvity, Inc. (U.S.)
  • Pacific Biosciences of California Inc. (U.S.)
  • Danaher Corporation (U.S.)
  • Oxford Nanopore Technologies Plc. (U.K.)
  • MGI Tech Co., Ltd. (China)

The market can be segmented based on offerings, applications, end users, and geography.

Offerings

Among the offerings analyzed, the next-generation sequencing (NGS) segment is expected to dominate the market, capturing a 63.9% share by 2024. This dominance is attributed to the high prevalence of neurological disorders, rising healthcare expenses, and significant initiatives focused on advancing diagnostic and therapeutic approaches via NGS.

Applications

In the applications segment, research applications are forecasted to maintain a leading market position with a 61.6% share in 2024. The rapid integration of advanced solutions such as next-generation sequencing (NGS), PCR, and microarrays in academic and research institutions, substantial investments in genomics research, and the increasing demand for personalized medicine are driving factors for this segment's growth.

End Users

Examining end users, the pharmaceutical and biotechnology companies segment is projected to dominate with a 44.6% market share in 2024. Elevated R&D investments by these companies, facilitating the adoption of advanced solutions like next-generation sequencing, microarrays, and PCR technologies, coupled with a high incidence of neurological disorders, contribute to this segment's leading position.

Geography

Regionally, North America is expected to hold the largest market share, accounting for 47.2% in 2024. The growth in this market is primarily driven by increasing R&D expenditures in the pharmaceutical and biotechnology sectors, the presence of major market players, supportive government initiatives for genomics research, expanding applications for sequencing-based research, the rising incidence of neurological diseases, and a favorable reimbursement landscape.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/neurogenomics-market-6019

Key Questions Answered in the Report:

  • What is the revenue generated from the neurogenomics market globally, based on offering, application, and end user?
  • At what rate is the demand for neurogenomics solutions projected to grow globally for the next five to seven years?
  • What are the historical market size and growth rate for the neurogenomics market?
  • What are the major factors impacting the growth of this market?
  • What are the major opportunities for existing players and new entrants in the market?
  • Which offering, application, and end-user segments are expected to create major traction for the players in this market?
  • Who are the major players in the neurogenomics market? What are their specific product offerings in this market?
  • What are the recent developments in the neurogenomics market? What are the impacts of these strategic developments?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Comments

Post a Comment

Popular posts from this blog

The Power Players: 15 Influencing Micro-mobility Market Growth

  The newly published research report on   Micro-mobility Market Report   provides an in-depth comprehension of a rapidly growing market. It offers an extensive market outlook, covering all the major aspects such as Micro-mobility market share, size, trends, projected growth rate, and sales channels. Also, it examines the challenges, opportunities, and prospects for the market. An in-depth analysis of all the major market segments and regions has been provided in the report. Pictorial representations such as tables, graphs, and charts have also been used to help readers comprehend the information easily. Both quantitative and qualitative research methodologies have been used in the study to provide an in-depth market comprehension. It covers crucial information on supply chain challenges and how businesses can deal with them. The research report is a vital resource for stakeholders, investors, and anyone looking to develop effective marketing strategies and stay ahead of ...
Read more

Europe EV Battery Market - Opportunity Analysis And Industry Forecast (2022-2029)

  Meticulous Research®, a prominent market research firm, released a report titled " Europe EV Batteries Market  by Type (Li-ion, Ni-MH, SLA, Ultracapacitors, Solid-state Batteries), Capacity (<50 kWh, 51-100 kWh, 101-300 kWh, >300 kWh), Bonding Type (Wire, Laser), Form, Application, End User, and Country - Forecast to 2029" . The European EV battery market is projected to expand at a compound annual growth rate (CAGR) of 45.8% from 2022, reaching $94.41 billion by 2029 . This growth is primarily fueled by the rising global adoption of electric vehicles, falling battery prices, and the increasing localization of battery production. Additionally, the expanding use of battery-as-a-service presents lucrative growth opportunities for market participants. However, the market's growth may be somewhat hindered by a potential shortage in lithium mining capacity. Additionally, safety concerns related to EV batteries pose a significant challenge to the expansion of t...
Read more

Ventilators Market to be Worth $13.23 Billion by 2031

  Meticulous Research®, a prominent market research firm, released a report titled, ‘ Ventilators Market by Product (Instrument, Catheter, Mask, Tube) Mobility (Intensive Care, Portable) Interface (Invasive, Non-invasive) Age Group (Adult, Neonatal) Mode (Volume, Pressure, Dual) End User (Hospital, ASC, Home Care) – Global Forecast to 2031’. Meticulous Research® predicts that the ventilators market will expand to $13.23 billion by 2031 , growing at a compound annual growth rate (CAGR) of 8.3% between 2024 and 2031. This growth is fuelled by several factors, including the increased availability of intensive care units (ICUs) and ICU beds, higher rates of respiratory diseases, urbanization leading to increased pollution, a growing elderly population, and more instances of preterm births. Nonetheless, obstacles such as the expensive nature of ventilators and the preference for alternative oxygenation therapies hinder market advancement. Rising demand for therapeutic devices for ho...
Read more